Despite its success, clinical and logistical roadblocks to mRNA cancer vaccine development remain.
Martin Lachs
Advertisement
Martin Lachs, PhD, is VP, Project Management Oncology at ICON.
Articles by Martin Lachs
Advertisement
Latest Updated Articles
Logistical Considerations in mRNA Vaccine DevelopmentPublished: September 15th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
